Trial Information

Observational Study of Fostamatinib as Second Line Therapy in Adult Patients with Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology